The global enteric disease testing market has been in good stead in recent years due to notable advances in enteric disease testing. Adoption of technologically-driven testing methodologies, especially in developed countries to understand the anatomy and physiology of pathogens is pushing the enteric diseases testing market to make strides. Molecular diagnostic testing is increasingly becoming a key component of enteric disease testing to contribute to the growth of this market.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258
Enteric diseases are a group of health conditions that are associated with consuming contaminated food or water and microbial toxins that affect the gastrointestinal tract. Enteric diseases can be completely asymptomatic to have mild to severe symptoms such as bloody diarrhea, abdominal cramps, fever, and weight loss that varies from person to person depending on the severity of the condition. It is difficult to get an accurate number of cases of enteric illness as many individuals mistake their symptoms with other gastrointestinal infections.
The growth behavior of the enteric disease testing market and the underlying governing factors have been explained at length in a new market study by Transparency Market Research.
Q: Which segments are poised for growth in the coming years?
A: The key segments of the enteric disease testing market depending on disease indication are bacterial enteric disease, viral enteric disease, and parasitic enteric disease. Salmonellosis, shigellosis, and campylobacteriosis are some key bacterial enteric diseases. Leading viral enteric diseases include norovirus and rotavirus, whereas leading parasitic enteric disease include giardiasis, cryptosporidiosis, and amebiasis. Of them, bacterial enteric diseases held almost 58.5% share of the overall market in 2016. Growing incidence of E.coli infection and C.difficile infection along with product development are boosting the growth of bacterial enteric disease segment.
The parasitic enteric disease segment, on the other hand, is the second leading revenue contributor to the enteric disease testing market. Rising trend of leisure travel from developed regions to developing regions accounts as the key factor behind the growth of parasitic enteric disease segment.
Q: How are key regions faring in terms of growth in the global market
A: The key regions into which the global enteric disease testing market is divided are North America, Asia, Latin America, Europe, and the Middle East and Africa. Powered by the U.S. with almost 94% share in 2016, North America is a prominent region for enteric disease testing. Europe is another key region for enteric disease testing. Strong pharmaceuticals industry in developed nations of North America and Europe that has helped to furnish new drugs and new testing methodologies for enteric diseases has served to boost this market. In addition to that, increasing leisure travel from developed nations of North America and Europe to relatively underdeveloped countries in Africa, Central and South America, and Southeast Asia is also a key factor behind the prevalence of enteric diseases. This is boosting the enteric disease testing market in these regions.
Vis-à-vis growth, Asia Pacific is likely to emerge as a key market for enteric disease testing. The region accounts for more than 50% of the world’s total population wherein many countries lack safe drinking water and sanitation systems to prevent water-borne and air-borne diseases. The enteric disease testing market in the region is primarily driven by the high prevalence of enteric diseases, rising awareness, and increasing adoption of advanced diagnostic tests in continuously improving economy of China and India with escalating healthcare expenditure.